A Florida company with a technology for reformulating oily drugs so they can be delivered intravenously is moving its headquarters and research lab to Wisconsin. An investment by Kegonsa Partners and a grant from the state Department of Commerce were instrumental. Click here to read a Milwaukee Journal-Sentinel story.
Recent Posts
- InsideWis: Nobel Prize winner Watson ‘complex’ mentor for UW-Madison researcher November 14, 2025
- WARF: WARF celebrates centennial with $206.9 million commitment to UW-Madison research November 13, 2025
- Wisconsin Technology Council announces 2025 Wisconsin Innovation Award winners November 13, 2025
- WisBusiness: RoddyMedical expanding sales team as device rolls out to larger markets November 12, 2025
- Powering the cloud: Data center energy challenges and opportunities set for Nov. 25 luncheon November 10, 2025
- WisBusiness: the Podcast with Laura Strong, Valency Fund November 7, 2025